protein drug

Study on Modified Guar Gum Microsphere as A Protein Drug Carrier

改性瓜尔胶微球用作蛋白药物载体的研究

The recombinant protein drug usually has a short half-life after intravenous ( IV) or subcutaneous ( SC) administration. The methods of prolonging the half-life of recombinant protein drug in common use are mainly based on three principles: 1 Amplifying the molecule weight of protein drug;

重组蛋白药物经静脉和皮下注射后通常半衰期较短，目前延长蛋白药物半衰期的方法主要基于三种原理：1、增大蛋白药物分子量；

Study on Protein Drug Delivery System Based on Liposomes Technology

基于脂质体技术的蛋白质类药物传递系统的研究

In the recent twenty years, PEC were studied broadly due to their special properties, and applied in many fields such as environment, new coatings materials, template polymerization, protein separation, drug delivery and molecule self-assembly.

由于其具有很多优异性，近二十年来得到了广泛的研究，并在环保、新型膜材料、模板聚合、蛋白质分离、药物载体及分子自组装等领域得到了广泛的应用。

The role of mechanism of drug atorvastatin calcium leads to apoptosis-related protein expression changes that promote cell proliferation of Bcl-2, MMP-2 protein expression decreased, while Bax protein in regulating expression, bax/ bcl-2 increases, which may be one of the mechanisms.

药物的作用机制是阿托伐他汀钙导致细胞凋亡相关的蛋白表达量发生改变，使促使细胞增生的Bcl-2、MMP-2蛋白表达降低，同时调节Bax蛋白高表达，bax/bcl-2增大，这可能是其作用机制之一。

In the process of transportation and translation, drug would bond with tissue protein, including receptor, and body fluid protein.

在转运和转化的过程中，药物会与组织蛋白（包括受体）及体液蛋白相结合。

G protein-coupled receptor and drug targets for therapy in rheumatoid arthritis

与类风湿关节炎相关的G蛋白偶联受体及治疗药物作用靶点

And that's huge. In fact, it means that if a patient comes in and they're resistant to this drug, then if we give them a chemical to block this protein, then we can treat them again with the same drug.

实际上，这意味着如果病人他们对这种药产生抗药性，如果我们给他们这种化学物质来阻止这种蛋白，那么我们又可以用同样的药重新治疗他们。

The drug is a recombinant protein, called Factor VIII , which is necessary to help blood clot.

该药是一种重组蛋白质, 叫第8因子, 能有效地帮助血液凝固.

The Study of Drug-Protein Interaction in Vitro Based on Fluorescence Detection

基于荧光检测的在线药物蛋白反应研究

Most potent drug target can be identifying among large number of non-homologous protein through protein interaction network analysis.

大多数有效的药物靶点能够通过蛋白质相互作用网络分析，在大量非同源蛋白质间识别。

The spectroscopy analysis shows that all those quinolone drugs can react with BLf or HSA and form a drug-protein compound.

光谱分析结果表明，上述喹诺酮类药物都可以与牛乳铁蛋白或人血清白蛋白之间形成亲和力较强的复合物。